Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $3.5 million.

  • Wave Life Sciences' Change in Accured Expenses fell 11.54% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 5447.96%. This contributed to the annual value of $4.3 million for FY2024, which is 68743.09% up from last year.
  • As of Q3 2025, Wave Life Sciences' Change in Accured Expenses stood at $3.5 million, which was down 11.54% from $5.2 million recorded in Q2 2025.
  • Wave Life Sciences' Change in Accured Expenses' 5-year high stood at $6.9 million during Q4 2024, with a 5-year trough of -$13.3 million in Q1 2025.
  • For the 5-year period, Wave Life Sciences' Change in Accured Expenses averaged around $237684.2, with its median value being $3.3 million (2021).
  • In the last 5 years, Wave Life Sciences' Change in Accured Expenses crashed by 10201.25% in 2022 and then soared by 766896.55% in 2023.
  • Wave Life Sciences' Change in Accured Expenses (Quarter) stood at $3.5 million in 2021, then soared by 85.76% to $6.5 million in 2022, then plummeted by 35.28% to $4.2 million in 2023, then surged by 65.06% to $6.9 million in 2024, then crashed by 50.12% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $5.2 million for Q2 2025, and -$13.3 million during Q1 2025.